Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Balagholi, Sahar, Dabbaghi, Rasul, Eshghi, Peyman, Mousavi, Seyed Asadollah, Heshmati, Farhad, Mohammadi, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605792/
https://www.ncbi.nlm.nih.gov/pubmed/33162341
http://dx.doi.org/10.1016/j.transci.2020.102993
_version_ 1783604380857008128
author Balagholi, Sahar
Dabbaghi, Rasul
Eshghi, Peyman
Mousavi, Seyed Asadollah
Heshmati, Farhad
Mohammadi, Saeed
author_facet Balagholi, Sahar
Dabbaghi, Rasul
Eshghi, Peyman
Mousavi, Seyed Asadollah
Heshmati, Farhad
Mohammadi, Saeed
author_sort Balagholi, Sahar
collection PubMed
description Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopathogenesis and coagulopathy induced by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 patients.
format Online
Article
Text
id pubmed-7605792
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-76057922020-11-03 Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy Balagholi, Sahar Dabbaghi, Rasul Eshghi, Peyman Mousavi, Seyed Asadollah Heshmati, Farhad Mohammadi, Saeed Transfus Apher Sci Article Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopathogenesis and coagulopathy induced by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 patients. Published by Elsevier Ltd. 2020-12 2020-11-02 /pmc/articles/PMC7605792/ /pubmed/33162341 http://dx.doi.org/10.1016/j.transci.2020.102993 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Balagholi, Sahar
Dabbaghi, Rasul
Eshghi, Peyman
Mousavi, Seyed Asadollah
Heshmati, Farhad
Mohammadi, Saeed
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title_full Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title_fullStr Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title_full_unstemmed Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title_short Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
title_sort potential of therapeutic plasmapheresis in treatment of covid-19 patients: immunopathogenesis and coagulopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605792/
https://www.ncbi.nlm.nih.gov/pubmed/33162341
http://dx.doi.org/10.1016/j.transci.2020.102993
work_keys_str_mv AT balagholisahar potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy
AT dabbaghirasul potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy
AT eshghipeyman potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy
AT mousaviseyedasadollah potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy
AT heshmatifarhad potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy
AT mohammadisaeed potentialoftherapeuticplasmapheresisintreatmentofcovid19patientsimmunopathogenesisandcoagulopathy

Ejemplares similares